News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Semaglutide may extend benefits in COVID-19
14 Aug 2026
byAudrey Abella
In a prespecified secondary analysis of the phase III FLOW trial, semaglutide reduces the risk of serious infections and COVID-19 events in individuals with type 2 diabetes (T2D) and chronic kidney disease (CKD).
Semaglutide may extend benefits in COVID-19
14 Aug 2026
Nutritional anaemia raises mortality, readmission risks in patients with AECOPD
13 Aug 2026
byStephen Padilla
Anaemia affects nearly one in five patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and contributes to increased postdischarge mortality and readmission, a study has found. Its most common subtype is nutritional anaemia, followed by anaemia of chronic disease (ACD).







